 Myriad Genetics's intention to patent human genes led to intense controversy.Because genes occur naturally in every human, in addition to raising moral questions, patenting them would constitute an obstacle to biomedical research worldwide.Additionally, the company was selling its breast cancer diagnostic test for a price many described as "outrageous"